Submission ID # Submission Title Submitter ID # Submitter Name
Basics of Diagnosing and Treating Common
2222 Arrhythmias 1612 Henry Green
Histoplasmosis: Current diagnostic and
2203 treatment strategies 1545 Audrey Cook
Feline Urethral Obstruction: Traditional and
2217 Alternative Approaches to Treatment 1610 Edward Cooper
Medical Management of Feline Chronic
1955 Kidney Disease 1440 Jessica Quimby
Advances in the management of small
2190 animal seizures 1481 R. Bentley
Oncology Drug Development Challenges and
2063 Opportunities 1516 Melissa Paoloni
The Commandments-Secrets to Improve
1990 Quality of Life for the Cancer Patient 1467 Gregory Ogilvie
Novel Strategies for the Prevention of
2195 Johne's Disease in Cattle 1601 Marie-Eve Fecteau
1956 Enhancing appetite in the feline patient 1440 Jessica Quimby
Pharmacodynamic Monitoring of
2141 Cyclosporine Therapy in Dogs 1567 Todd Archer
2096 The Drugs of CPCR 1537 Amy Breton
2091 Unusual Colloids 1537 Amy Breton
Street Street line 2
Clinical Sciences, SVM 625 Harrison St., Lynn Hall
CVM, Small Animal Clinical Sciences 4474 TAMU
601 Vernon Tharp Street
CVM, Clinical Sciences 300 W.Drake Rd.
Lynn Hall G152 625 Harrison St.
COP 37 Convent Dr., Rm. 2144
Carlsbad Research Center 2310 Faraday Ave
New Bolton Center, SVM 382 W. Street Rd.
CVM, Clinical Sciences 300 W.Drake Rd.
119 Canna Ave.
9 Park Ave.
9 Park Ave.
Street line 3 City State / Province Country Zip / Postal Code
W. Lafayette IN USA
College Station TX USA
Columbus OH USA
Ft. Collins CO USA
W. Lafayette IN USA
Bethesda MD USA
Carlsbad CA USA
Kennett Square PA USA
Ft. Collins CO USA
Starkville MS USA
Tewksbury ME USA
Tewksbury ME USA
Number E-mail Company Name
494-1107 greenh@purdue.edu Purdue University
845-2351 akcook@cvm.tamu.edu Texas A&M University
292-3551 cooper.1697@osu.edu The Ohoi State
221-4535 jquimby@colostate.edu Colorado State University
839-4696 rbentley@purdue.edu Purdue University
451-2937 melissa_paoloni@yahoo.com NIH/NCI
594-0794 gogilvie@aol.com Angel Care Cancer Ctr. for Animals
925-6208 mfecteau@vet.upenn.edu University of Pennsylvania
221-4535 jquimby@colostate.edu Colorado State University
325-3432 tarcher@cvm.msstate.edu Mississippi State University
Veterinary Emergency & Specialty Center of
458-6041 newfieldamy@hotmail.com New England
Veterinary Emergency & Specialty Center of
458-6041 newfieldamy@hotmail.com New England
Professional Designation Job Title / Position
DVM, DACVIM (Cardiology) Associate Professor of Cardiology
BVM&S, MRCVS, DACVIM (SAIM), DECVIM-
CA Clinical Associate Professor
Assitant Professor- Clinical
DVM, DACVIM (SAIM)
DVM, DACVIM (Oncology) Special Fellow
DVM, DACVIM (Small Animal Internal
Medicine & Oncology), DECVIM-CA
DVM, DACVIM (SAIM)
DVM
More
Division / Department Series? than 1 Lecture Type Audience
Speaker?
Veterinary Clinical Sciences No No Technician Program Small Animal
SA Clinical Sciences No No Comprehensive Review Small Animal
No No Comprehensive Review Small Animal
No No Technician Program Small Animal
No No Comprehensive Review Small Animal
No No Comprehensive Review Small Animal
No No Comprehensive Review Small Animal
School of Veterinary Medicine, Clinical
Studies-New Bolton Center No No Comprehensive Review Food Animal
No No Comprehensive Review Small Animal
No No Comprehensive Review Small Animal
No No Technician Program Small Animal
No No Technician Program Small Animal
Category 1 If other, explain Category 2
Cardiology Pharmacology
Infectious Disease Pharmacology
Nephrology - Urology Pharmacology
Nephrology - Urology Pharmacology
Neurology Pharmacology
Oncology Pharmacology
Oncology Pharmacology
Pharmacology Infectious Disease
Pharmacology Nephrology - Urology
Pharmacology Other
Pharmacology Pharmacology
Pharmacology Pharmacology
If other, explain Comments
The advent of new drugs and treatments has
dramatically enhanced our ability to improve
the quality of life for the cancer patient.
Similarly, palliative, supportive care and the
acceptance of molecular therapeutics to
maintain rather than eradicate cancer has re-
ignighted interest in innovative,
comprehensive, compassionate care
approaches. In this interactive lecture, I will
discuss ways to improve quality of life for
the cancer patient by relieving pain, nausea,
diarrhea, anorexia etc for specialists and
generalists alike.
50-Word Description Possible Sponsorship?
This lecture will review the basics of
diagnosing common arrhythmias and drugs
used to treat them.Case examples will be
utilized as part of the presentataion wth the
potential for audience members to
participate generating answers to the ECG's
and potential treatment options. Not at this time
Histoplasmosis is a common systemic
mycotic infection in many regions of the
USA, and is reported in both dogs and cats.
This lecture will review recent advances in
diagnostic and monitoring methods for this
disease. In addition, the pros and cons of
new therapeutic options will be discussed.
The lecture involves a comprehensive review
of all aspects of management of feline
urethral obstruction including emergency
stabilization and catheterization, diagnostic
evaluation, and post-obstructive care.
Current areas of research and alternative
(low-cost) treatment options, including
management without urethral
catheterization, are also discussed.
Multiple therapies are used to manage feline
chronic kidney disease. Understanding why
these therapies are important can be helpful
in client education and leads to increased
compliance and technicians should be
familiar with this information. The
pathophysiological impact of various
medications for the management of feline
kidney disease will be discussed. Hill's, Nestle Purina, Vetquinol, Pfizer, Bayer
Presenting advances in feline and canine
epilepsy, including a prospective clinical trial
of intermittent levetiracetam therapy.
Oncology drug development is challenging as
costs increase, pipelines overlap, and the
regulatory process becomes more complex.
Overview of regulatory framework for drug
approval, adaptive clinical trial strategies to
shorten the clinical trial process, and use of
molecular profiling modalities to clarify likely
responders and non responders. Snap shot
of trials with new endpoints: OBD, TTP.
The advent of new drugs and treatments has
dramatically enhanced our ability to improve
the quality of life for the cancer patient.
Similarly, palliative, supportive care and the
acceptance of molecular therapeutics to
maintain rather than eradicate cancer has re-
ignighted interest in innovative,
comprehensive, compassionate care
approaches. This presentation will focus on
new approaches. Hills, Merrial, Pfizer, Abbott, Iams,
The presentation will provide a review of the
most recent advances in the use of
pharmaceuticals for the prevention and/or
control of Johne's disease in cattle. More
specifically, the use of antimicrobials as
prophylactic agents to aid in the control of
MAP infections during the neonatal period
will be discussed, including the author's
recent research data on the use of gallium
nitrate.
Maintaining adequate nutrition is critical in
veterinary patients, particularly cats who are
at risk for hepatic lipidosis. The
pathophysiology of nutrition as it relates to
healing, the immune system and overall
prognosis will be discussed. A review of
nutritional management of the feline patient
will be presented, including recently
published information about the use of the Hill's, Nestle Purina, Royal Canin, Pfizer
mirtazapine in cats. (cerenia),
I will present an evidence-based review of
the current uses of cyclosporine in dogs. I
will compare therapeutic drug monitoring in
human and veterinary medicine, and review
the use of flow cytometry and qRT-PCR for
the pharmacodynamic monitoring of
cyclosporine in dogs, ending with a
discussion of individualized therapeutic
monitoring. Novartis
Discusses both common and uncommon
drugs used in CPCR. Participants will walk
away with a full understanding of what each
drug does and when to use it.
The use of colloids has increased in
veterinary medicine in the past 10 years.
With the advances in medicine, new and
exciting colloids are available. Attendees will
learn about both natural and synthetic
colloids and how they are used in veterinary
medicine.